Nutrition IN Liver AND GI Disease — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Nutrition IN Liver AND GI Disease.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Nutrition IN Liver AND GI Disease and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Alali M, Naveed AK, Alnounou A, Alharami M, et al. Beyond Endoscopy: A Narrative Review of the Emerging Role of Gastroenterologists in Obesity Medicine, GLP-1 (Glucagon-Like Peptide-1) Therapy, and Metabolic Care Cureus, 2026.PMID 42382903
[2]Budai BC, Panait R, Laczkó B, Cai G, et al. Immunonutrition Decreases Postoperative Complications in Gastrointestinal Cancer-A Systematic Review and Meta-analysis of Randomized Controlled Trials Adv Nutr, 2026.PMID 42331289
[3]Hadzic N, Dionisi-Vici C, Vara R Current status in paediatric liver transplantation for inherited metabolic diseases J Pediatr Gastroenterol Nutr, 2026.PMID 42328777
[4]Hernandez-Gea V, Paradis V, Guindi M, Alves VAF, et al. A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF Hepatol Int, 2026.PMID 42207228
[5]Hernández-Gea V, Paradis V, Guindi M, Alves VAF, et al. A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF J Hepatol, 2026.PMID 42191459
[6]Hernandez-Gea V, Paradis V, Guindi M, Alves VAF, et al. A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF Ann Hepatol, 2026.PMID 42191146
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Nutrition IN Liver AND GI Disease and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Alali M, Naveed AK, Alnounou A, Alharami M, et al. Beyond Endoscopy: A Narrative Review of the Emerging Role of Gastroenterologists in Obesity Medicine, GLP-1 (Glucagon-Like Peptide-1) Therapy, and Metabolic Care Cureus, 2026.PMID 42382903
[2]Budai BC, Panait R, Laczkó B, Cai G, et al. Immunonutrition Decreases Postoperative Complications in Gastrointestinal Cancer-A Systematic Review and Meta-analysis of Randomized Controlled Trials Adv Nutr, 2026.PMID 42331289
[3]Hadzic N, Dionisi-Vici C, Vara R Current status in paediatric liver transplantation for inherited metabolic diseases J Pediatr Gastroenterol Nutr, 2026.PMID 42328777
[4]Hernandez-Gea V, Paradis V, Guindi M, Alves VAF, et al. A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF Hepatol Int, 2026.PMID 42207228
[5]Hernández-Gea V, Paradis V, Guindi M, Alves VAF, et al. A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF J Hepatol, 2026.PMID 42191459
[6]Hernandez-Gea V, Paradis V, Guindi M, Alves VAF, et al. A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF Ann Hepatol, 2026.PMID 42191146
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005